Health Medical Pharma

Micron gets $23.6m Gates Foundation grant to make needle-free vaccines

HQ Team November 20, 2023: Micron Biomedical, a US Atlanta-based medical device company, announced a $23.6 million grant from the Bill & Melinda.

Read More
Drugs Health Pharma

Injecting drugs or inhaling them may up chances of addiction: NIH

HQ Team November 10, 2023: A drug taken intravenously or inhaled proved to be more addictive as it enters the human brain more.

Read More
Drugs Health Pharma

BioNTech expects revenue to be lower in 2023 as Covid-19 vaccine sales fall

HQ Team October 16, 2023: Germany’s  BioNTech announced its partner Pfizer Inc.’s write-offs for inventory and other charges related to the Covid-19 Comirnaty.

Read More
Climate Health Pharma

Water crisis to threaten 5 billion people globally by 2050: WMO

HQ Team October 12, 2023: An estimated five billion people will face inadequate access to water at least a month, every year by.

Read More
Drugs Health Pharma

FDA nod for Pfizer’s combination therapy for non-small cell cancer

HQ Team October 12, 2023: The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer. The FDA.

Read More
Climate Health Pharma

US, China, AI developers invent new ways to predict earthquakes

HQ Team October 10, 2023: US and Chinese researchers have developed an artificial intelligence-based platform to predict earthquakes with 70% accuracy. The AI.

Read More
Drugs Health Pharma

Amgen completes $27.8b acquisition of Horizon Therapeutics

Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two.

Read More
Drugs Health Pharma

Scientists behind Covid-19 mRNA vaccine bag Nobel medicine prize

HQ Team October 2, 2023: Hungarian-born biochemist Katalin Kariko and US immunologist Drew Weissman jointly won the Nobel Prize in Physiology or Medicine.

Read More
Health Medical Pharma

Cordis acquires medical device maker MedAlliance for $1.1 billion

HQ Team October 2, 2023: Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its.

Read More
Drugs Health Pharma

Pfizer enters Hong Kong migraine market, its first in Asia

HQ Team September 29, 2023: Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market.

Read More